Revvity | PKI - Ebitda



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 17.93B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


Ebitda 更改 日
Agilent USD 577M 77M 2026-06
Align Technology USD 229.14M 31.74M 2026-03
Bio Techne USD 115.94M 763K 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Celltrion KRW 19.64B 1.85B 2026-03
Charles River Laboratories USD 272.95M 43.14M 2026-06
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 190M 61M 2026-06
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Illumina USD 330M 80M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
IQVIA Holdings USD 994M 62M 2026-06
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Laboratory Of America USD 767.7M 162.1M 2026-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pharma Mar EUR 700K 2.01M 2026-06
Qiagen NV USD 207.66M 59.56M 2026-06
Quest Diagnostics USD 648M 91M 2026-06
Quidel USD 129.3M 20.6M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Sartorius EUR 280.5M 13.2M 2026-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Tilray USD 8.36M 1.82M 2025-09
Waters USD 712M 545M 2026-06
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03